1. 1087Immunogenicity and Safety of 3-Dose Primary Vaccination with Combined DTPa-HBV-IPV/Hib Vaccine in Canadian Aboriginal and non-Aboriginal Infants. (December 2014) Authors: Scheifele, David W.; Ferguson, Murdo; Predy, Gerald; Dawar, Meena; Assudani, Deepak; Kuriyakose, Sherine; Van Der Meeren, Olivier; Han, Htay Htay Journal: Open forum infectious diseases Issue: Volume 1(2014)Supplement 1 Page Start: S320 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE). Issue 10370 (7th January 2023) Authors: Merola, Joseph F; Landewé, Robert; McInnes, Iain B; Mease, Philip J; Ritchlin, Christopher T; Tanaka, Yoshiya; Asahina, Akihiko; Behrens, Frank; Gladman, Dafna D; Gossec, Laure; Gottlieb, Alice B; Thaçi, Diamant; Warren, Richard B; Ink, Barbara; Assudani, Deepak; Bajracharya, Rajan; Shende, Vishv... Journal: Lancet Issue: Volume 401:Issue 10370(2023) Page Start: 38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial. Issue 10222 (8th February 2020) Authors: Ritchlin, Christopher T; Kavanaugh, Arthur; Merola, Joseph F; Schett, Georg; Scher, Jose U; Warren, Richard B; Gottlieb, Alice B; Assudani, Deepak; Bedford-Rice, Kathy; Coarse, Jason; Ink, Barbara; McInnes, Iain B Journal: Lancet Issue: Volume 395:Issue 10222(2019) Page Start: 427 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL). Issue 10370 (7th January 2023) Authors: McInnes, Iain B; Asahina, Akihiko; Coates, Laura C; Landewé, Robert; Merola, Joseph F; Ritchlin, Christopher T; Tanaka, Yoshiya; Gossec, Laure; Gottlieb, Alice B; Warren, Richard B; Ink, Barbara; Assudani, Deepak; Bajracharya, Rajan; Shende, Vishvesh; Coarse, Jason; Mease, Philip J Journal: Lancet Issue: Volume 401:Issue 10370(2023) Page Start: 25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Bioequivalence, safety and immunogenicity of BI 695501, an adalimumab biosimilar candidate, compared with the reference biologic in a randomized, double-blind, active comparator phase I clinical study (VOLTAIRE®-PK) in healthy subjects. (1st December 2016) Authors: Wynne, Christopher; Altendorfer, Mario; Sonderegger, Ivo; Gheyle, Lien; Ellis-Pegler, Rod; Buschke, Susanne; Lang, Benjamin; Assudani, Deepak; Athalye, Sandeep; Czeloth, Niklas Journal: Expert opinion on investigational drugs Issue: Volume 25:Number 12(2016:Dec.) Page Start: 1361 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Effect of bimekizumab on symptoms and impact of disease in patients with psoriatic arthritis over 3 years: results from BE ACTIVE. (5th July 2022) Authors: Mease, Philip J; Asahina, Akihiko; Gladman, Dafna D; Tanaka, Yoshiya; Tillett, William; Ink, Barbara; Assudani, Deepak; de la Loge, Christine; Coarse, Jason; Eells, Jason; Gossec, Laure Journal: Rheumatology Issue: Volume 62:Number 2(2023) Page Start: 617 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib vaccine in Canadian Aboriginal and non-Aboriginal infants. Issue 16 (15th April 2015) Authors: Scheifele, David W.; Ferguson, Murdo; Predy, Gerald; Dawar, Meena; Assudani, Deepak; Kuriyakose, Sherine; Van Der Meeren, Olivier; Han, Htay-Htay Journal: Vaccine Issue: Volume 33:Issue 16(2015) Page Start: 1897 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib vaccine in Canadian Aboriginal and non-Aboriginal infants. Issue 16 (15th April 2015) Authors: Scheifele, David W.; Ferguson, Murdo; Predy, Gerald; Dawar, Meena; Assudani, Deepak; Kuriyakose, Sherine; Van Der Meeren, Olivier; Han, Htay-Htay Journal: Vaccine Issue: Volume 33:Issue 16(2015) Page Start: 1897 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OA36 Bimekizumab in patients with psoriatic arthritis: achievement and maintenance of Psoriatic Arthritis Response Criteria responses through 3 years in a phase 2b open-label extension study. (23rd April 2022) Authors: Tillett, William; McInnes, Iain B; McGonagle, Dennis; Jadon, Deepak R; Ink, Barbara; Assudani, Deepak; Coarse, Jason; Eells, Jason; Coates, Laura C Journal: Rheumatology Issue: Volume 61(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OP0108 DUAL NEUTRALISATION OF IL-17A AND IL-17F WITH BIMEKIZUMAB IN PATIENTS WITH ACTIVE PSA: OVERALL AND TNF-INHIBITOR-NAÏVE POPULATION RESULTS FROM A 48-WEEK PHASE 2B RANDOMISED STUDY. (June 2019) Authors: Ritchlin, Christopher T.; Kavanaugh, Arthur; Merola, Joseph F.; Schett, Georg; Scher, Jose U.; Warren, Richard B.; Assudani, Deepak; Kumke, Thomas; Ink, Barbara; Mcinnes, Iain Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗